MC1476A1 - Derives de la pyrrolidine - Google Patents

Derives de la pyrrolidine

Info

Publication number
MC1476A1
MC1476A1 MC821598A MC1598A MC1476A1 MC 1476 A1 MC1476 A1 MC 1476A1 MC 821598 A MC821598 A MC 821598A MC 1598 A MC1598 A MC 1598A MC 1476 A1 MC1476 A1 MC 1476A1
Authority
MC
Monaco
Prior art keywords
oxo
hydroxy
formula
hydrogen
pyrrolidinyl
Prior art date
Application number
MC821598A
Other languages
English (en)
French (fr)
Inventor
Werner Aschwanden
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4849/81A external-priority patent/CH647234A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1476A1 publication Critical patent/MC1476A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Electronic Switches (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
MC821598A 1981-07-24 1982-07-22 Derives de la pyrrolidine MC1476A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4849/81A CH647234A5 (en) 1981-07-24 1981-07-24 Pyrrolidine derivatives
CH276882 1982-05-05

Publications (1)

Publication Number Publication Date
MC1476A1 true MC1476A1 (fr) 1983-06-17

Family

ID=25691358

Family Applications (1)

Application Number Title Priority Date Filing Date
MC821598A MC1476A1 (fr) 1981-07-24 1982-07-22 Derives de la pyrrolidine

Country Status (34)

Country Link
US (3) US4476308A (enExample)
EP (1) EP0071216B1 (enExample)
AT (2) AT384424B (enExample)
AU (1) AU557651B2 (enExample)
BG (1) BG38334A3 (enExample)
CA (1) CA1176251A (enExample)
CS (1) CS226746B2 (enExample)
DD (1) DD202540A5 (enExample)
DE (2) DE3274851D1 (enExample)
DK (1) DK157848C (enExample)
EG (1) EG15921A (enExample)
ES (1) ES8307743A1 (enExample)
FI (1) FI75158C (enExample)
FR (1) FR2515179A1 (enExample)
GB (2) GB2110207B (enExample)
HK (1) HK53788A (enExample)
HU (1) HU187777B (enExample)
IE (1) IE53428B1 (enExample)
IL (1) IL66341A (enExample)
IT (1) IT1152287B (enExample)
LU (1) LU84294A1 (enExample)
MC (1) MC1476A1 (enExample)
MT (1) MTP915B (enExample)
NL (1) NL8202922A (enExample)
NO (1) NO159592C (enExample)
NZ (1) NZ201297A (enExample)
OA (1) OA07151A (enExample)
PH (1) PH19149A (enExample)
PT (1) PT75314B (enExample)
RO (1) RO84097B (enExample)
SE (1) SE8204445L (enExample)
SG (1) SG22788G (enExample)
SU (1) SU1281172A3 (enExample)
ZW (1) ZW14482A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
IT1173763B (it) * 1984-03-30 1987-06-24 Proter Spa Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico,procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US4758585A (en) * 1985-08-16 1988-07-19 Warner-Lambert Company Saturated cycloalkyl (B) pyrrol-1 (2H)- acetic acid amides and derivatives thereof
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
JPS6422883A (en) * 1987-07-17 1989-01-25 Sanwa Kagaku Kenkyusho Co 1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
US5021568A (en) * 1988-04-22 1991-06-04 Shipov Alexandr G Lactam-1-acetic acid carbalkoxymethyl esters and method for preparing same
IT1245870B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2100641A1 (en) * 1992-07-23 1994-01-24 Hiromu Matsumura Novel piperidine derivatives and process for preparation thereof
US5679798A (en) * 1996-11-22 1997-10-21 Mona Industries, Inc. Silicone monomers having a carboxyl functional group thereon
DE02080416T1 (de) * 1996-11-22 2004-04-15 Mona Industries, Inc. Eine Karboxylgruppe enthaltende Sillikonmonomere und -oligomere
US6686477B2 (en) * 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
ES2865504T3 (es) * 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
EA037187B1 (ru) * 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075280B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
US4372960A (en) * 1980-12-12 1983-02-08 Warner-Lambert Company Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
BE892942A (fr) * 1982-04-23 1982-10-25 Ucb Sa Procede pour prevenir ou attenuer les psychoses iatrogenes causees par les medicaments a activite cytostatique.

Also Published As

Publication number Publication date
GB2110207B (en) 1985-09-04
SE8204445L (sv) 1983-01-25
IL66341A0 (en) 1982-11-30
FR2515179A1 (fr) 1983-04-29
HU187777B (en) 1986-02-28
RO84097B (ro) 1984-06-30
PH19149A (en) 1986-01-15
DK157848C (da) 1990-07-23
IL66341A (en) 1986-12-31
GB2110207A (en) 1983-06-15
DD202540A5 (de) 1983-09-21
SG22788G (en) 1988-07-15
GB2152038B (en) 1986-01-02
LU84294A1 (de) 1984-03-22
ATA286382A (de) 1987-04-15
CA1176251A (en) 1984-10-16
PT75314B (en) 1985-11-29
SE8204445D0 (sv) 1982-07-23
EP0071216B1 (de) 1986-12-30
HK53788A (en) 1988-07-22
US4476308A (en) 1984-10-09
IT8222335A0 (it) 1982-07-09
US4650878A (en) 1987-03-17
ATE24488T1 (de) 1987-01-15
IE821768L (en) 1983-01-24
NL8202922A (nl) 1983-02-16
US4476308B1 (enExample) 1987-03-10
ES514267A0 (es) 1983-08-16
IE53428B1 (en) 1988-11-09
FI75158C (fi) 1988-05-09
DK157848B (da) 1990-02-26
MTP915B (en) 1985-12-28
SU1281172A3 (ru) 1986-12-30
AT384424B (de) 1987-11-10
EG15921A (en) 1986-09-30
OA07151A (fr) 1984-03-31
ZW14482A1 (en) 1983-02-09
DK317382A (da) 1983-01-25
DE3274851D1 (en) 1987-02-05
DE3227649A1 (de) 1983-02-10
AU557651B2 (en) 1987-01-08
FI75158B (fi) 1988-01-29
EP0071216A3 (en) 1983-09-07
IT8222335A1 (it) 1984-01-09
RO84097A (ro) 1984-05-12
GB8426076D0 (en) 1984-11-21
IT1152287B (it) 1986-12-31
FI822543L (fi) 1983-01-25
PT75314A (en) 1982-08-01
US5034402A (en) 1991-07-23
NO159592C (no) 1989-01-18
NZ201297A (en) 1985-12-13
NO822222L (no) 1983-01-25
AU8615882A (en) 1983-01-27
ES8307743A1 (es) 1983-08-16
EP0071216A2 (de) 1983-02-09
NO159592B (no) 1988-10-10
CS226746B2 (en) 1984-04-16
FR2515179B1 (enExample) 1985-01-18
BG38334A3 (en) 1985-11-15
GB2152038A (en) 1985-07-31
FI822543A0 (fi) 1982-07-19

Similar Documents

Publication Publication Date Title
MC1476A1 (fr) Derives de la pyrrolidine
EP0018342B1 (fr) Nouveaux dérivés du glycerol, leurs procédés de préparation ainsi que les compositions pharmaceutiques les contenant
CA1265517A (fr) DERIVES DE L'ACIDE .alpha.-[OXO-2 HEXAHYDRO-2,4,5,6,7, 7A THIENO (3,2-C) PYRIDYL-5] PHENYL ACETIQUE, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION THERAPEUTIQUE
EP0165919B1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
FR2678938A1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
MC1639A1 (fr) Derives de la glycerine
CA2552565C (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0229566B1 (fr) Dérivés de la 1-benzène sulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
FR2546166A1 (fr) Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
MC1795A1 (fr) Derives de banzazecine
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
MC2226A1 (fr) Oxetannones
EP0240398B1 (fr) Dérivés dissymétriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procédés de préparation et utilisation en thérapeutique
MC1960A1 (fr) Derives d'acide hydrocinnamique
CS214837B2 (en) Method of making the pyrrolidine derivatives
CA1308728C (fr) Derives de la 1-benzoyl 2-oxo 5-alcoxy pyrrolidine, leur preparation, leur application comme medicament et les compositions les renfermant
CA2301739A1 (fr) Analogues optiquement purs de la camptothecine, intermediaire de synthese optiquement pur et son procede de preparation
MC2105A1 (fr) Derives de tetrahydronaphtalene
MC1287A1 (fr) Derives de cyclohexadiene
EP0294295B1 (fr) Dérivés de la 1-arylsulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
KR890000768B1 (ko) 피롤리딘 유도체 및 이의 제조방법
CA1311487C (fr) Derives de 1-benzyl 2-oxo 5-alcoxy pyrrolidine, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
Lau et al. Synthesis of penicillin N and isopenicillin N

Legal Events

Date Code Title Description
YP Annual fee paid